Arcadia Biosciences (RKDA) Misses Q1 EPS by 3c

Arcadia Biosciences (NASDAQ: RKDA) reported Q1 EPS of ($0.10), $0.03 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $1.02 million versus the consensus estimate of $1.2 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Credo Technology shares rise on analyst support and conference comments
• Deutsche Bank Upgrades Danone SA (BN:FP) (DANOY) to Hold